Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 429-460-4 | CAS number: 7078-98-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted to GLP and in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not effect the quality of the relevant results.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- The temperature and relative humidity (61-75°F and 31-75%, respectively) exceeded the preferred ranges (63-77°F and 30-70%, respectively) during the study. These occurrences are considered to have had no adverse effect on the outcome of the study.
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Hartley-derived albino guinea pigs were received at SLI from Hilltop Lab Animals, Inc., Scottdale, Pennsylvania.
- Age at study initiation: Young adult.
- Housing: The animals were housed individually in suspended stainless steel cages.
- Diet (e.g. ad libitum): PMI Certified Guinea Pig Chow was provided ad libitum throughout the study.
- Water (e.g. ad libitum): Municipal tap water, treated by reverse osmosis, was available ad libitum throughout the study.
- Acclimation period: Minimum of five days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 61-75°F
- Humidity (%): 31-75%.
- Air changes (per hr): 10-15 air changes/hour.
- Photoperiod (hrs dark / hrs light): 12-hour light/12-hour dark. - Route:
- intradermal and epicutaneous
- Vehicle:
- propylene glycol
- Concentration / amount:
- Main study:
Induction phase: intradermal injection, 3% (w/w) in propylene glycol.
topical application, 100%.
Challenge phase: topical application, 100% - Route:
- epicutaneous, semiocclusive
- Vehicle:
- propylene glycol
- Concentration / amount:
- Main study:
Induction phase: intradermal injection, 3% (w/w) in propylene glycol.
topical application, 100%.
Challenge phase: topical application, 100% - No. of animals per dose:
- 20 animals in test group, 10 animals in control group.
- Details on study design:
- RANGE FINDING TESTS:
The test article was then utilized at 100% and at 10%, 25% and 50% w/w in propylene glycol for the topical range-finding study and at 0.1%, 1%, 3% and 5% w/w in propylene glycol for the intrademal rangefinding study.
Topical Range-Finding Study: The results of the range-finding study indicated that a test article concentration of 100% was considered appropriate for topical induction.
Intradermal Range-Finding Study:
Due todosing difficulties at 5.0% intradermally and yet similar dermal responses observed at 3.0%, a test article concentration of 3.0% w/w in
propylene glycol was considered appropriate for intradermal induction.
MAIN STUDY
A. INDUCTION EXPOSURE
Intradermal induction:
On the day following clipping (day 0), three pairs of intradermal injections were made in the clipped area of ali sensitization study animals. The
injections were kept within an approximate 2 x 4 cm area with one row of three injections on each side of the back bone.
Injections for the test animals were:
a) 0.1 ml of Freund's Complete Adjuvant (FCA) emulsion
b) 0.1 ml of 3.0% test article in propylene glycol
c) 0.1 ml of 3.0% test article in FCA emulsion
Topical induction:
On the day prior to topical induction (day 6), the guinea pigs had the hair removed from the scapular area with a small animal clipper. Care was taken
to avoid abrading the skin during the clipping procedures. Following clipping, 0.5 mL of 10% w/w sodium lauryl sulfate in petrolatum was spread over the intradermal injection sites of all study animals.
On study day 7, any residual sodium lauryl sulfate preparation was removed with a dry gauze and the appropriate material was prepared and applied to the animals as indicated below:
0.15 g 100% test material (moistened with 10 drops propylene gycol)
Approximately 48 hours after dosing, the elastic wrap, tape and patch were removed. The test sites were wiped with gauze moistened in propylene
glycol to remove test article residue and the animals were retumed to their cages.
B. CHALLENGE EXPOSURE
On the day prior to challenge dose administration, the hair was removed from the right side of the test and challenge control animals with a small animal clipper. Care was taken to avoid abrading the skin during the clipping procedures.
On the following day (day 21), the appropriate concentration of the test article was prepared and applied to the appropriate animals as indicated below:
0.15 g 100% test material (moistened with 10 drops propylene gycol). - Challenge controls:
- Intradermal induction:
Injections for the challenge and rechallenge control animals were as indicated below:
a: 0.1 mL of FCA emulsion
b: 0.1 mL of propylene glycol
c: 0.1 mL of 3.0% propylene glycol/FCA emulsion
Topical induction:
Challenge control: 0.8 mL of 100% propylene glycol.
Rechallenge control: 0.8 mL of of 100% propylene glycol.
Challenge:
Challenge control: 0.15 g 100% test material (moistened with 10 drops propylene gycol). - Positive control substance(s):
- yes
- Remarks:
- alpha-Hexylcinnamaldehyde.
- Positive control results:
- Positive control: alpha-Hexylcinnamaldehyde.
Following topical induction and intradermal induction at 5.0% w/v alpha-Hexylcinnamaldehyde in propylene glycol and challenge at levels of 1.0% and 0.5% w/v alpha-Hexylcinnamaldehyde in propylene glycol, a contact sensitization response was observed, thereby demonstrating the susceptibility of the test system to this sensitizing agent. - Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 16
- Total no. in group:
- 20
- Clinical observations:
- No toxic symptoms were observed
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100%. No with. + reactions: 16.0. Total no. in groups: 20.0. Clinical observations: No toxic symptoms were observed.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 16
- Total no. in group:
- 20
- Clinical observations:
- No toxic symptoms were observed
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100%. No with. + reactions: 16.0. Total no. in groups: 20.0. Clinical observations: No toxic symptoms were observed.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No toxic symptoms observed
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No toxic symptoms observed.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No toxic symptoms observed
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No toxic symptoms observed.
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- There was evidence of reactions indicative of skin sensitisation to the test substance under the conditions of the test and the substance is considered to be a sensitizer in guinea pigs.
- Executive summary:
Method:
The dermal sensitization potential of the test substance was evaluated in Hartley-derived albino guinea pigs. Ten male and ten female guinea pigs received intradermal injections of 3.0% w/w test substance in propylene glycol along with injections of FCA and test substance in FCA. One week later, the test animals received a topical application of 100% test substance.
Challenge and rechallenge control animals received similar intrademnal and topical treatments except propylene glycol was used in place of the test substance. Following a two-week rest period, a challenge was performed whereby the twenty test and ten previously untreated (naive) challenge control guinea pigs were topically treated with 100% test substance. Challenge responses in the test animals were compared with those of the challenge control animals.
Resuts:
Test substance:
Following challenge with 100% test substance, some degree of sensitisation was noted in 16/20 test animals at the 24-hour and 48-hour scoring interval.
Group mean dermal scores were noted to be higher in the test animals as compared with the challenge control animals.
Positive control:
Following topical induction and intradermal induction at 5.0% w/v alpha-Hexylcinnamaldehyde in propylene glycol and challenge at levels of 1.0% and 0.5% w/v alpha-Hexylcinnamaldehyde in propylene glycol, a contact sensitization response was observed, thereby demonstrating the susceptibility of the test system to this sensitizing agent.
Conclusion:
There was evidence of reactions indicative of skin sensitisation to the test substance under the conditions of the test and the substance is considered to be a sensitizer in guinea pigs.
Reference
Following challenge with 100% test substance, some degree of sensitisation was noted in 16/20 test animals at the 24-hour and 48-hour scoring interval.
Group mean dermal scores were noted to be higher in the test animals as compared with the challenge control animals.
One animal was observed to have red extremities which was possibly an indication of a whole body sensitization response.
The sensitization study animals gained weight during the test period and generally appeared in good health.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
Skin sensitisation:
The dermal sensitization potential of the test substance was evaluated in Hartley-derived albino guinea pigs. Ten male and ten female guinea pigs received intradermal injections of 3.0% w/w test substance in propylene glycol along with injections of FCA and test substance in FCA. One week later, the test animals received a topical application of 100% test substance.
Challenge and rechallenge control animals received similar intrademal and topical treatments except propylene glycol was used in place of the test substance. Following a two-week rest period, a challenge was performed whereby the twenty test and ten previously untreated (naive) challenge control guinea pigs were topically treated with 100% test substance. Challenge responses in the test animals were compared with those of the challenge control animals.
Following challenge with 100% test substance, some degree of sensitisation was noted in 16/20 test animals at the 24-hour and 48-hour scoring interval.
Group mean dermal scores were noted to be higher in the test animals as compared with the challenge control animals.
There was evidence of reactions indicative of skin sensitisation to the test substance under the conditions of the test and the substance is considered to be a sensitizer in guinea pigs.
Migrated from Short description of key information:
There was evidence of reactions indicative of skin sensitisation to the test substance under the conditions of the test and the substance is considered to be a sensitizer in guinea pigs. Using the potency characterisation criteria in ECHA Guidance on Information Requirements and Chemical Safety Assessment, the substance is considered a moderate sensitiser. As no EC3 could be derived for sensitization, a qualitative approach to risk management must be adopted.
Justification for classification or non-classification
The substance is classified for skin sensitisation.
Following challenge with 100% test substance, some degree of sensitisation was noted in 16/20 test animals at the 24-hour and 48-hour scoring interval.
There was evidence of reactions indicative of skin sensitisation to the test substance under the conditions of the test and the substance is considered to be a sensitizer in guinea pigs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.